USPTO serial 79097713
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 7, 2021 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Nov 7, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 8, 2019 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jan 31, 2019 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jan 31, 2019 | INPC | INVALIDATION PROCESSED | — |
| Jan 18, 2019 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 18, 2018 | C71T | CANCELLED SECTION 71 | — |
| Aug 4, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 23, 2012 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 22, 2012 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 22, 2012 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 10, 2011 | GPAR | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | — |
| Oct 11, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 26, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 6, 2011 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 25, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 23, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 21, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 21, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 17, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |